Investor Veto Rights, Corporate Governance and the Turkish Legal Perspective

The Legal Side of Building | No. 02
Ownership Is Not Control
A founder builds a company from the ground up. After years of developing the product and finding customers, the business attracts an investor: $500,000 for a 20% stake. The founder keeps 80%.
Then, during negotiations, the investor asks for approval rights. Taking on debt. Issuing new shares. Approving the annual budget. Hiring senior executives. Signing significant contracts.
None of these rights changes the investor's 20%. Yet each one changes who decides.
In No. 01 of this series, we said every investment agreement must answer two questions:
The legal question: can this agreement actually be implemented?The business question: are the consequences of implementing it acceptable?
The same two questions apply to control. Can the governance rights an investor negotiates actually operate under Turkish law? And if they do, can the company still run?
Ownership is a percentage. Control is a legal structure.
When Investor Protection Becomes Operational Control
Veto rights are not the problem. Their scope is.
An investor who commits substantial capital has a legitimate interest in decisions that could change the nature or risk of the investment: selling the company, issuing a new class of shares, a major restructuring. Few founders would object to that.
Compare two agreements:
Agreement A | Agreement B | |
Investor consent needed for | Sale of the company, new share classes, major restructuring | All of A, plus hires above a salary level, contracts above a low threshold, budget changes, new markets |
What the investor protects | The value of the investment | The investment and the daily business |
Founder's room to operate | Broad | Narrow |
Now imagine a software company negotiating an enterprise contract. The customer wants an answer this week. The deal is ordinary business, but it exceeds the approval threshold. If consent takes three weeks, the opportunity may be gone.
The investor has done nothing unreasonable. The problem is structural.
A governance mechanism designed to protect capital can also become a source of operational friction.
What Turkish Corporate Law Actually Allows
In Türkiye, where a right is written decides how strong it is.
US venture deals spread investor protections across the charter, an investor rights agreement and a voting agreement. In a Turkish joint-stock company (anonim şirket), the Commercial Code (TTK) divides powers between the general assembly and the board, and the articles of association may depart from the Code only where the Code expressly allows it (Art. 340). That leaves three places an investor protection can live, each with different strength.
1. The shareholders' agreement. It binds the shareholders who sign it. It does not change the statutory powers of the company's organs. If the founders breach it, the corporate decision usually stands, and the investor's claim is usually contractual. Where the company itself is a party to the agreement, the analysis can differ.
2. The board's voting rules (Art. 390). By default the board meets with a majority of its members and decides by a majority of those present. The articles may set a stricter quorum. If the votes are tied, the matter is deferred to the next board meeting; if they remain tied there, the proposal is deemed rejected (Art. 390/3).
Two things must be kept apart here:
A heavier quorum (for example, unanimity, or four of five directors, for listed matters) applies to all directors equally. Its effect may be that the investor's nominee can block a decision, but the rule itself is a statutory tool.
A personal veto for one named director ("no decision without the investor director's vote") is something different. It treats one director's vote as weightier than the others', and its validity under Turkish law is far less certain. A drafter who wants the effect should reach for the first tool, not the second.
3. Privileged shares and the special assembly (Arts. 421, 454, 478).
Privileges attached to a class of shares can be written into the articles (Art. 478), and the articles may tighten the general assembly's statutory voting thresholds (Art. 421). The strongest protection is the special assembly of privileged shareholders: certain general assembly resolutions, and certain board capital increase decisions, that could impair the privileged shareholders' rights cannot be implemented without that assembly's approval (Art. 454).
The special assembly does not provide a general investor veto. Its protective function is limited to the decisions specified in Art. 454 that may prejudice the rights attached to privileged shares, and it follows its own statutory procedure, quorum and exceptions. Designed well, though, it is the closest Turkish equivalent to a protective provision that truly binds the company.
A contractual right to approve a decision is not the same as a corporate power to prevent it from taking effect.
A note on board seats: the articles can give a class or group of shares the right to be represented on the board (Art. 360), which is the statutory way to secure an investor's board seat. Shares carrying that right count as privileged shares (Art. 360/2), so the special assembly protection described above can apply to them too. But a director nominated this way still owes duties of care and loyalty to the company (Art. 369). A board seat gives the investor a voice. It does not turn the director into the investor's agent.
What Happens When the Agreement Is Breached?
A veto that binds only the shareholders rarely undoes a deal the company has already signed.
Suppose the shareholders' agreement says the company may not sign contracts above $250,000 without investor consent. The CEO signs a $400,000 contract anyway. What happens?
Toward the counterparty: Under TTK Art. 371/3, limits on representation authority have no effect against third parties acting in good faith. The only limits that can be relied on are registered and published ones restricting authority to the head office or a branch, or requiring joint signatures. An internal approval threshold is not one of them. Art. 371/4 adds that a transaction contrary to the articles or a general assembly resolution does not prevent good-faith third parties from relying on it. In most cases, the contract binds the company.
Inside the company: The breach is real, but its consequences are internal: a damages claim against the shareholders who promised compliance, a contractual penalty if the agreement provides one, or a trigger for other negotiated remedies.
This is why drafting a veto right is not just a list of decisions. It also requires deciding what happens when the list is ignored: a penalty, a put option, a change in board composition, or something else the parties can actually enforce.
Investor protection is measured not by how many restrictions an agreement contains, but by whether they work when they are breached.
What Changes for Limited Liability Companies?
In a limited company, the founders may hold more tools than they realise, and so may the investor.
Many Turkish startups are limited liability companies (limited şirket), not joint-stock companies. The logic of control is different:
Managers, not a board. The company is run by one or more managers (müdür), and at least one partner must hold management and representation authority (Art. 623). With several managers, the general assembly appoints a chair, and, unless the articles provide otherwise, the chair's vote decides a tie (Art. 624/3) — unlike the joint-stock rule, where a repeated tie means rejection.
More room to reserve decisions for the partners. The articles can submit certain managers' decisions to the general assembly for approval (Art. 625/2; see also Art. 616/2-a). This gives a limited company a corporate-law route to investor consent that is closer to a true veto than a shareholders' agreement alone. The partners' approval does not, however, remove or limit the managers' liability (Art. 625/2).
Fundamental decisions already need a qualified majority. Under Art. 621, decisions such as capital increases, restricting pre-emptive rights, introducing privileged voting shares, restricting share transfers and changing the business purpose need two-thirds of the votes represented and a majority of the entire voting capital. A 20% shareholding does not automatically confer a blocking minority. Its practical effect depends on the applicable thresholds, meeting participation and the distribution of voting rights.
Third parties are still protected. Internal limits on managers' representation authority are treated as in joint-stock companies (Art. 629, referring to the joint-stock rules), so the Art. 371 analysis above applies.
The practical lesson: before importing a US term sheet, check which company form the startup has. The same veto may be best placed in the shareholders' agreement in one form and in the articles in the other.
Questions to Ask Before Signing
Seven questions separate a protection that works from one that only reads well.
Question | Which of the two questions it answers | Who should ask it |
Which decisions need investor consent, and are they extraordinary or operational? | Are the consequences acceptable? | Founder |
Are the monetary thresholds realistic for the company's actual revenue and deal sizes? | Are the consequences acceptable? | Founder |
How is consent requested, how fast must the investor answer, and what happens if they don't? | Are the consequences acceptable? | Both |
Is each right in the shareholders' agreement, the board's quorum rules or the articles? | Can it be implemented? | Investor |
Is a board-level protection a heavier quorum for all directors, or a personal veto for one? | Can it be implemented? | Both |
What is the remedy if the right is breached, given that third parties may be protected? | Can it be implemented? | Investor |
Is the company a joint-stock or a limited company, and does the structure fit that form? | Can it be implemented? | Both |
A poorly structured veto gives investors false security. An overly broad one can slow the company precisely when it needs to move. Both lead to disputes when clarity matters most.
The Takeaway
A founder with 80% may still be unable to make certain decisions alone. An investor with 20% may hold real governance power. Neither is unfair by itself.
What matters is that the rights match what both sides expect, and that Turkish law lets them work that way. In practice, that means knowing which rights live in a contract, which live in the board's rules, and which live in the articles.
As in No. 01, an agreement can be legally enforceable and still be commercially restrictive.
Capital has a price beyond dilution. Sometimes it is paid in decisions the company can no longer make on its own.
Sources
Turkish Commercial Code No. 6102 (Official Gazette No. 27846, 14 February 2011), Arts. 340, 360, 369, 371, 390, 421, 454, 478, 616, 620–621, 623–625, 629. Official text: mevzuat.gov.tr.
This article is for general information and is not legal advice. Whether an investor consent right is enforceable depends on the company's form, its articles, the applicable legislation and the facts of the transaction.




Comments